GUERBET (GBT.PA) Stock Price, Quote, News and Overview
EPA:GBT - Euronext Paris - Matif - FR0000032526 - Common Stock - Currency: EUR
GBT.PA Quote, Performance and Key Statistics
EPA:GBT (3/28/2025, 2:06:20 PM)
20.5
-1.7 (-7.66%)
The current stock price of GBT.PA is 20.5 EUR. In the past month the price decreased by -16.85%. In the past year, price decreased by -32.42%.
GBT.PA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ESL.DE | ESSILORLUXOTTICA | 39.75 | 123.48B | ||
| 1EL.MI | ESSILORLUXOTTICA | 39.66 | 123.21B | ||
| EL.PA | ESSILORLUXOTTICA | 39.2 | 121.77B | ||
| CBHD.DE | COLOPLAST-B | 33.27 | 20.56B | ||
| GENT.OL | GENTIAN DIAGNOSTICS ASA | 16.38 | 724.74M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 83.15M | ||
| ALCJ.PA | CROSSJECT | N/A | 68.88M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 54.50M | ||
| IVN.MI | IVISION TECH SPA | N/A | 18.25M |
Related stock screener links
About GBT.PA
Company Profile
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,920 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.
Company Info
GUERBET
15 rue des Vanesses, Zone Paris Nord II
Villepinte ILE-DE-FRANCE FR
Employees: 2920
Company Website: https://www.guerbet.com/
Investor Relations: http://www.guerbet.com/en/investors.html
Phone: 33145915000
GUERBET / GBT.PA FAQ
What is the stock price of GUERBET today?
The current stock price of GBT.PA is 20.5 EUR. The price decreased by -7.66% in the last trading session.
What is the ticker symbol for GUERBET stock?
The exchange symbol of GUERBET is GBT and it is listed on the Euronext Paris - Matif exchange.
On which exchange is GBT.PA stock listed?
GBT.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for GUERBET stock?
8 analysts have analysed GBT.PA and the average price target is 42.59 EUR. This implies a price increase of 107.73% is expected in the next year compared to the current price of 20.5. Check the GUERBET stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GUERBET worth?
GUERBET (GBT.PA) has a market capitalization of 259.12M EUR. This makes GBT.PA a Micro Cap stock.
How many employees does GUERBET have?
GUERBET (GBT.PA) currently has 2920 employees.
What are the support and resistance levels for GUERBET (GBT.PA) stock?
GUERBET (GBT.PA) has a resistance level at 26.22. Check the full technical report for a detailed analysis of GBT.PA support and resistance levels.
Is GUERBET (GBT.PA) expected to grow?
The Revenue of GUERBET (GBT.PA) is expected to grow by 6.69% in the next year. Check the estimates tab for more information on the GBT.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GUERBET (GBT.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GBT.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GBT.PA, evaluating the profitability, health, valuation and growth aspects
- GUERBET (GBT.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GUERBET (GBT.PA) Sales and EPS estimates to see what analysts future expectations are.
- GUERBET (GBT.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GUERBET (GBT.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- GUERBET (GBT.PA) Stock Chart to make your own analysis
- GUERBET (GBT.PA) Latest news and press-releases to stay up to date.
Does GUERBET (GBT.PA) stock pay dividends?
GUERBET (GBT.PA) has a dividend yield of 1.88%. The yearly dividend amount is currently 0.5. Check the full fundamental report for a detailed analysis of GBT.PA dividend history, reliability and sustainability.
When does GUERBET (GBT.PA) report earnings?
GUERBET (GBT.PA) will report earnings on 2025-03-26, after the market close.
What is the Price/Earnings (PE) ratio of GUERBET (GBT.PA)?
The PE ratio for GUERBET (GBT.PA) is 7.77. This is based on the reported non-GAAP earnings per share of 2.64 and the current share price of 20.5 EUR. Check the full fundamental report for a full analysis of the valuation metrics for GBT.PA.
GBT.PA Technical Analysis
GBT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GBT.PA. GBT.PA has only an average score on both its financial health and profitability.
GBT.PA Financial Highlights
Over the last trailing twelve months GBT.PA reported a non-GAAP Earnings per Share(EPS) of 2.64. The EPS increased by 177.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.97% | ||
| ROA | 3.14% | ||
| ROE | 8.43% | ||
| Debt/Equity | 0.97 |
GBT.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to GBT.PA. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 119.14% and a revenue growth 6.69% for GBT.PA